RESISTANCE TO LOOP DIURETICS - WHY IT HAPPENS AND WHAT TO DO ABOUT IT

被引:107
作者
BRATER, DC [1 ]
机构
[1] UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DEPT INTERNAL MED,DALLAS,TX 75235
关键词
D O I
10.2165/00003495-198530050-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:427 / 443
页数:17
相关论文
共 86 条
[51]   EFFECT OF PROSTAGLANDIN INHIBITION ON NATRIURESIS OF DRUG-INDUCED RENAL VASODILATATION [J].
KIRSCHENBAUM, MA .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1977, 13 (06) :1103-1112
[52]   CONTINUOUS INFUSION OF FRUSEMIDE IN REFRACTORY EDEMA [J].
LAWSON, DH ;
GRAY, JMB ;
HENRY, DA ;
TILSTONE, WJ .
BRITISH MEDICAL JOURNAL, 1978, 2 (6135) :476-476
[53]   RENAL PROSTAGLANDINS AND REGULATION OF BLOOD-PRESSURE AND SODIUM AND WATER HOMEOSTASIS [J].
LEE, JB ;
PATAK, RV ;
MOOKERJEE, BK .
AMERICAN JOURNAL OF MEDICINE, 1976, 60 (06) :798-816
[54]   ARACHIDONIC-ACID METABOLISM, PROSTAGLANDINS AND THE KIDNEY [J].
LEVENSON, DJ ;
SIMMONS, CE ;
BRENNER, BM .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (02) :354-374
[55]  
MCGIFF JC, 1979, FED PROC, V38, P89
[56]  
NIES AS, 1983, J PHARMACOL EXP THER, V226, P27
[57]   EFFECT OF FUROSEMIDE IN CONGESTIVE HEART-FAILURE [J].
NOMURA, A ;
YASUDA, H ;
MINAMI, M ;
AKIMOTO, T ;
MIYAZAKI, K ;
ARITA, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :177-182
[58]   RENAL TUBULAR SECRETION AND EFFECTS OF FUROSEMIDE [J].
ODLIND, B ;
BEERMANN, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :784-790
[59]  
ODLIND B, 1979, J PHARMACOL EXP THER, V208, P515
[60]  
ODLIND B, 1979, J PHARMACOL EXP THER, V211, P238